Surgical Irrigation Market Report 2026

The surgical irrigation market size has grown strongly in recent years. It will grow from $5.48 billion in 2025 to $5.78 billion in 2026 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to increasing number of surgical procedures, rising prevalence of hospital-acquired infections, advancements in surgical equipment technology, growing demand for effective wound cleansing, expansion of healthcare infrastructure.

The surgical irrigation market size is expected to see strong growth in the next few years. It will grow to $7.21 billion by 2030 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to increasing adoption of minimally invasive surgeries, rising demand for infection prevention solutions, growing investment in advanced surgical devices, expansion of outpatient surgical centers, increasing focus on patient safety and surgical outcomes. Major trends in the forecast period include increasing use of sterile and single-use irrigation products, rising demand for high-pressure and precision irrigation systems, growing preference for temperature-controlled irrigation solutions, expansion of minimally invasive surgical irrigation techniques, development of antimicrobial and medicated irrigation fluids.

The increasing number of surgical procedures is expected to drive the expansion of the surgical irrigation market in the coming years. Surgical procedures refer to medical interventions in which a surgeon utilizes specialized instruments to diagnose, treat, or repair a condition through direct physical manipulation of the body. The volume of surgical procedures is rising due to the growing prevalence of chronic diseases, which frequently require surgical intervention to manage or address their associated complications. Surgical irrigation assists surgical procedures by rinsing the operative area with sterile solutions to eliminate debris and microorganisms, ensuring a clear surgical field for the surgeon, reducing the risk of infection, and enabling more accurate and efficient procedures. For instance, according to the 2024 annual report by Intuitive Surgical Inc., a US-based medical device company, approximately 2,683,000 surgical procedures were performed using da Vinci surgical systems, increasing from around 2,286,000 procedures in 2023 and 1,875,000 procedures in 2022, indicating consistent year-over-year growth in usage. Therefore, the increasing number of surgical procedures is driving the growth of the surgical irrigation market.

Leading companies operating in the surgical irrigation market are focusing on developing innovative solutions, such as pre-mixed sterile wound irrigation systems, to enhance patient safety and reduce surgical site infections. Pre-mixed sterile wound irrigation systems are ready-to-use, sterile solutions that effectively flush debris, microorganisms, and foreign materials from surgical wounds, helping reduce the risk of infections, improve patient outcomes, and streamline surgical workflows by eliminating the need for on-site preparation. For example, in November 2025, Becton, Dickinson and Company, a U. S. -based medical device manufacturing company, launched the BD Surgiphor Surgical Wound Irrigation System, an innovative sterile, ready-to-use solution designed to improve surgical wound care. The system contains a trusted antiseptic preservative that helps reduce bacterial load in wounds, minimizing the risk of surgical site infections. Unlike traditional irrigation methods that require preparation and manual mixing, Surgiphor is pre-mixed and easy to handle, allowing precise application during surgery. Its design streamlines workflow in the operating room, reduces preparation time, and supports evidence-based practices for safer surgical outcomes. This product is particularly valuable for hospitals aiming to enhance patient safety and operational efficiency.

In August 2024, ARCHIMED S. A., a France-based healthcare investment firm, acquired Irrimax Corporation for an undisclosed amount. With this acquisition, ARCHIMED intends to strengthen its presence in the rapidly growing wound care and surgical consumables market while expanding Irrimax’s product portfolio, geographic reach, and innovation capabilities. Irrimax Corporation is a US-based medical technology company specializing in antimicrobial wound treatment and irrigation solutions.

Major companies operating in the surgical irrigation market are Cardinal Health Inc., Johnson & Johnson, Medtronic plc, Medline Industries LP, Stryker Corporation, Becton Dickinson and Company, Baxter International Inc., B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Olympus Corporation, Smith & Nephew plc, STERIS plc, Teleflex Incorporated, KARL STORZ SE & Co. KG, Cook Medical LLC, CONMED Corporation, CooperSurgical Inc., Richard Wolf GmbH, Mölnlycke Health Care AB, ARCHIMED.

North America was the dominating region in the surgical irrigation market in 2025. Asia-Pacific is expected to be the rapidly expanding region during the forecast period. The regions covered in the surgical irrigation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the surgical irrigation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The surgical irrigation market consists of sales of irrigation systems, pulsatile lavage devices, irrigation pumps, tubing sets, and sterile irrigation fluids. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.